Update - Notification regarding unquoted securities - AVE
Released
Released
Announcement PDF
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
Update Summary
Entity name
AVECHO BIOTECHNOLOGY LIMITED
Announcement Type
Update to previous announcement
Date of this announcement
Wednesday October 01, 2025
Reason for the update
Correction to the number of options issued on 27 May 2025 following a typographical error. The total number of unquoted
options issued on 27 May 2025 were 142,618,373. The total number of unquoted options (AVEAS) on issue is
146,612,017.
Refer to next page for full details of the announcement
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
1/7
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
Part 1 - Entity and announcement details
1.1 Name of entity
AVECHO BIOTECHNOLOGY LIMITED
We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.
1.2 Registered number type
Registration number
ABN
32056482403
1.3 ASX issuer code
AVE
1.4 The announcement is
Update/amendment to previous announcement
1.4a Reason for update to a previous announcement
Correction to the number of options issued on 27 May 2025 following a typographical error. The total number of unquoted
options issued on 27 May 2025 were 142,618,373. The total number of unquoted options (AVEAS) on issue is
146,612,017.
1.4b Date of previous announcement to this update
27/5/2025
1.5 Date of this announcement
1/10/2025
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
2/7
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
Part 2 - Issue details
2.1 The +securities the subject of this notification are:
+Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX
2.2a This notification is given in relation to an issue of +securities in a class which is not quoted on ASX and
which:
has an existing ASX security code ("existing class")
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
3/7
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
Part 3B - number and type of +securities the subject of this notification (existing class) where issue has not previously been notified to
ASX in an Appendix 3B
ASX +security code and description
AVEAS : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES
Date the +securities the subject of this notification were issued
27/5/2025
Will these +securities rank equally in all respects from their issue date with the existing issued
+securities in that class
Yes
Were any of the +securities issued to +key management personnel (KMP) or an +associate?
Yes
Provide details of the KMP or +associates being issued +securities.
Name of KMP
Name of registered holder
Number of +securities
Gregory Collier
Barwon Biotechnology Pty Ltd
6,338,595
Katherine Connell
Katherine Ellen Danielle Connell
3,169,298
Mathew McNamara
Pelehj145 Pty Ltd <M&L McNamara
Super Fund>
3,169,298
Ross Murdoch
Ross Murdoch
3,169,298
Paul Gavin
Paul Gavin
63,385,941
Roksani Libinakis
Roksani Libinakis
31,692,971
Please provide a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme
or a summary of the terms
https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02656674-3A616854&v=7bc42bd11d85
3ed5e8c28f2ffcd6a069ee5cd6b4
Any other information the entity wishes to provide about the +securities the subject of this notification
The 15,846,489 unquoted Options to Directors were issued following Shareholders approval at the 2025 Annual General
Meeting of the Company (pursuant to ASX Listing Rule 10.14).
The remaining 126,771,884 unquoted Options were issued to employees under Exception 13 (ASX Listing Rule 7.2).
All unquoted Options have an exercise price of $0.0066 each and expire on 27 November 2028.
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
4/7
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
Issue details
Number of +securities
142,618,373
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
5/7
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
Part 4 - +Securities on issue
Following the issue, conversion or payment up of the +securities the subject of this notification, the +securities of
the entity will comprise:
The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if
other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.
4.1 Quoted +securities (Total number of each +class of +securities issued and quoted on ASX)
ASX +security code and description
Total number of
+securities on issue
AVE : ORDINARY FULLY PAID
3,173,463,679
AVEOA : OPTION EXPIRING 10-MAY-2026
2,147,130,063
4.2 Unquoted +securities (Total number of each +class of +securities issued but not quoted on ASX)
ASX +security code and description
AVEAS : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
Total number of
+securities on issue
289,230,330
6/7
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
Part 5 - Other Listing Rule requirements
5.1 Were the +securities issued under an exception in Listing Rule 7.2 and therefore the issue
did not need any security holder approval under Listing Rule 7.1?
Yes
5.1a Select the number of the applicable exception in Listing Rule 7.2
13
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
7/7
Share your feedback
Discover